Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Nonprofit Harm Reduction Therapeutics targets an OTC switch of naloxone, an opioid antagonist used to reverse an opioid overdose. It aims to make the product available at low cost in 110,000 retail locations nationwide.
Latest From Consumer
Colgate Smart Electronic Toothbrush E1 is available exclusively on Apple.com and in select Apple stores for $99.95. The product is similar to a device sold in Europe by French firm Kolibree, which also introduced a children’s smart toothbrush featuring augmented reality to encourage brushing.
Support was unanimous during House Health Subcommittee markup for draft legislation on streamlining FDA's monograph system by eliminating public rulemakings from the process and allowing the agency to make decisions with administrative orders. Two-year exclusivity for some products didn't go over so well.
An updated draft includes a provision requiring FDA to report annually to the Energy and Commerce Committee and to the Senate HELP Committee on the agency's evaluation of the cough and cold monograph to determine whether to impose more stringent limits on formulations allowed for use by children under age 6.
Kramer Laboratories' claims for Fungi-Nail athlete's foot product referred to FDA and FTC after it refuses to comply with NAD's recommendation to modify the name. The firm, which agreed to modify packaging and commercial claims, was warned by FDA about the brand in 2005.
Prestige Brands' Dentek oral care brand hires a family who are YouTube performers to promote its floss picks in a 30-second rap parody promoting a 30-day family floss challenge, which will invite consumers to post photos on Facebook, Instagram and Twitter.
J&J's Vogue hair care brand has the “agile, fast, flexible mindset” the firm looks to emulate across its other consumer brands, says CEO Alex Gorsky says at the J.P. Morgan Healthcare Conference. However, that strategy will be a challenge for sun care, where the firm does not want to sacrifice valuable science.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.